Ad5-nCoV-IH

adenovirus type-5 vector-based SARS-CoV-2 vaccine (IH formulation) · CanSino Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad5-nCoV-IH, covering 2023-06-15 to 2023-06-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents [Phase 3]

See pricing